Glucagon-like peptide-1 (GLP-1), as one of the important targets for the treatment of type 2 diabetes mellitus (T2DM), has obvious therapeutic effect, short half-life and easy to be cleared
Rarely, it can lead to pancreatitis, which may present as persistent, severe abdominal pain (sometimes spreading to your back) and may be accompanied by vomiting
519 While early models have shown promising results, the application of GLP-1RAs in cancer treatment has not yet been established and requires further clinical trials
Two authors assessed the risk of bias for each study through five aspects: random sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting
Tandio, S
She blends clinical experience with a practical, integrative approach